Prof. Stéphane Supiot is a French clinical oncologist. He serves at the Institut de Cancérologie de l’Ouest and is affiliated with Nantes University. His primary research focuses on prostate cancer, particularly in radiotherapy, biochemical relapse management, and oligometastatic disease. He has led and contributed to multiple clinical trials (e.g. CARLHA 1 & 2, OLIGOPELVIS 1 & 2, POSTCARD..) investigating novel therapeutic and imaging strategies in prostate cancer radiotherapy. With over 250 publications, his work spans radiation oncology, hypoxia‐based treatments, and advanced imaging approaches.